Is CBD Legal in Vermont? Vermont Cannabis, Hemp, and CBD Laws (2026)

CBD can be sold through lawful hemp and licensed cannabis channels in Vermont. A product’s THC content, formulation, manufacturing method and marketing determine which restrictions apply. State hemp status also does not remove federal food and drug requirements.

Is CBD Legal in Vermont?

Compliant hemp-derived CBD does not require a medical cannabis card. CBD-rich cannabis products are available through the state’s licensed adult-use and medical systems. The Cannabis Control Board oversees the regulated cannabis market, but its hemp guidance draws a more detailed boundary than simply asking whether a product contains less than 0.3% THC.

For the national framework, see our guide to CBD legality in the United States. A seller’s website or a hemp label is not proof that a particular formulation can lawfully be sold.

Hemp-Derived CBD and Taxes

Oversight of Vermont hemp cultivation returned to the USDA on January 1, 2023, after the state agriculture program ended. Cultivation authorization should not be confused with approval of a finished CBD product.

The Department of Taxes generally treats retail CBD as taxable tangible personal property, subject to 6% state sales tax and applicable local option tax. Epidiolex qualifies for the prescription-drug exemption. The guidance also distinguishes CBD sold as part of a meal: meals-tax treatment can replace sales-tax treatment. These tax categories do not establish that adding CBD to a food is lawful.

The FDA’s separate rules prohibit adding CBD to food in interstate commerce or marketing it as a dietary supplement. Hemp classification is not FDA approval, and ordinary CBD oils or creams are not approved treatments for disease.

THC Limits, THCA and Prohibited Cannabinoids

The CCB’s hemp guidance classifies products as cannabis if they exceed 0.3% total theoretical THC by dry weight or 1.5 mg THC per serving. Its 10 mg package threshold has an exception when the CBD:THC ratio is greater than 20:1. That exception does not erase the other criteria.

THCA counts toward theoretical THC; the calculation adds delta-9 THC to THCA multiplied by 0.877. Beverage alcohol and marketing whose dominant appeal mimics THC intoxication can also put a product outside the hemp category.

Do not assume excluded products can simply move to dispensaries. Rule 2.17 prohibits production, manufacture, marketing, transfer and sale of hemp-derived intoxicating cannabinoids and synthetic cannabinoids, subject to its specific provisions. A cannabis license is not blanket permission to sell converted delta-8, delta-10 or similar products. See our background guides to delta-8 and HHC.

For existing regulated inventory, the CCB’s February 2026 decision required previously imported hemp-derived delta-9 distillate to be made into finished products by September 1, 2026. That deadline has passed; it is not an ongoing authorization for new distillate imports.

Federal Hemp Changes Have Two Deadlines

The federal hemp amendments are no longer all scheduled for November 12, 2026. Section 2019 of the September 2026 extension delays most provisions until December 11, 2026. Exclusions for products containing cannabinoids the cannabis plant cannot naturally produce remain scheduled for November 12.

The underlying 2025 law includes total-THC measurement and a finished-product exclusion above 0.4 mg per container of combined THC and specified similar-effect cannabinoids. That is a container threshold, not a CBD dose limit. State-compliant formulations can still fail the new federal definition, and isolate or broad-spectrum labels do not guarantee compliance.

The federal extension does not suspend Vermont’s existing restrictions. Businesses should assess the exact batch and product format against both systems, rather than treating the transition as permission to continue every existing hemp product.

Marijuana-derived CBD and adult-use cannabis in Vermont

Adults 21 and older can legally buy and use marijuana-derived CBD and other cannabis products in Vermont. The state took a two-step path that set it apart from most others. In 2018, Vermont became the first state to legalize adult possession and home cultivation through its legislature rather than a ballot question, with Act 86. It then authorized a taxed and regulated retail market with Act 164 in 2020, and licensed sales began on October 1, 2022.

Under Vermont’s adult-use possession law, a person 21 or older can possess up to two ounces of cannabis (or 10 grams of hashish) and grow up to two mature and four immature plants at home without penalty. Consuming cannabis in a public place is a civil violation that starts at a $100 fine. Going over the limit still carries consequences: possessing more than two ounces is a civil penalty, while larger quantities are a misdemeanor, though a first offense is usually eligible for the court diversion program before any conviction. Adult-use purchases are taxed at a 14% cannabis excise tax on top of the 6% sales tax, for a combined state rate of 20%, with applicable local option tax potentially increasing the total.

Lawmakers loosened some of these limits in 2026. Gov. Phil Scott signed S.278, “An act relating to cannabis,” which doubled the adult-use possession and purchase limit to two ounces (and the hashish limit to 10 grams), created a pilot program for cannabis events, authorized the governor to negotiate interstate cannabis commerce agreements that could take effect only if federal law changes to permit interstate transfers, and made other licensing changes. The higher limits took effect on July 1, 2026. However, the CCB’s June implementation decision increased the flower transaction limit to two ounces while leaving cannabis-product transaction limits unchanged; do not assume every concentrate or edible allowance doubled. For more on the businesses behind the counter, see our overview of Vermont’s cannabis licensing requirements. And whatever you buy, keep it in state: cannabis cannot legally cross state lines, a point we cover in our guide to traveling with cannabis. Vermont’s broader rules, including its THC potency caps and small-grower focus, are detailed in our cannabis in Vermont explainer.

Vermont’s medical cannabis program

Vermont runs a separate medical cannabis registry, and it gives registered patients access to higher-THC products that the adult-use market caps. The program dates to 2004 and is open to Vermont residents with a qualifying debilitating condition. According to the Cannabis Control Board, qualifying conditions include cancer, multiple sclerosis, HIV, AIDS, glaucoma, Crohn’s disease, Parkinson’s disease, PTSD, and ulcerative colitis, along with conditions that cause chronic pain, severe nausea, seizures, or wasting.

A registry card costs $50, is valid for three years, and requires a health care provider to verify the qualifying condition rather than prescribe cannabis. Registered patients can possess up to two ounces, grow up to six mature and twelve immature plants, pay no tax on their purchases, and buy products with higher potency than recreational customers. Those benefits are why a medical card still appeals even in a state with open adult-use sales.

Patients can also use retailers holding a medical-use endorsement. Confirm the retailer has that endorsement and that the transaction is recorded as a qualifying medical purchase; registration alone does not turn every adult-use checkout into a tax-exempt medical sale.

How to buy CBD safely in Vermont

Vermont’s CBD market is mature, but quality and labeling still vary, so the burden of vetting a product falls on the buyer. A few habits separate reliable CBD from the rest:

• Insist on third-party lab testing. Reputable brands publish a recent certificate of analysis (COA) from an independent lab that confirms the CBD content and screens for pesticides, solvents, heavy metals, and microbial contaminants.
• Be skeptical of miracle claims. CBD is studied for several uses, but a company that promises it cures serious disease is signaling more about its marketing than its science. Treat sweeping health claims as a red flag.
• Check the finished batch. An extraction method alone does not establish purity. Match the laboratory report to the package lot and review contaminant results as well as cannabinoid amounts.
• Verify sourcing claims. Organic certification can document farming practices, but it does not replace finished-product testing or establish medical effectiveness.
• Check actual THC rather than spectrum labels. Full-spectrum, broad-spectrum and isolate describe formulations. Use measured content to assess the applicable serving, package and federal limits.

Researching CBD Suppliers

Compare product-specific laboratory reports, ingredient lists, pricing and seller information. For cannabis products, use an appropriately licensed Vermont retailer; for hemp products, confirm that the exact formulation meets the applicable rules. A successful online checkout does not establish that shipment is lawful.

Check Vermont authorization for the exact product before ordering.

Choose the legal sales channel for the actual product and review its batch results before buying. Vermont’s hemp thresholds, licensed cannabis requirements and the separate federal transition each matter; no single marketing label answers all three questions.